Market closedNon-fractional
Tilray/TLRY
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About Tilray
Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company. The Company operates through four segments: Cannabis business, Distribution business, Beverage alcohol business and Wellness business. The Cannabis business segment is engaged in the production, distribution, sale, co-manufacturing, and advisory services of both medical and adult-use cannabis. The Distribution business segment is focused on the purchase and resale of pharmaceutical products to customers. The Beverage alcohol business segment is engaged in the production, marketing and sale of beverage and beverage alcohol products. The Wellness business segment includes hemp foods and hemp-based cannabidiol (CBD) consumer products. The Company offers a portfolio of adult-use brands and products and expands its portfolio to include new cannabis products and formats. Its brands include Good Supply, RIFF, Broken Coast, Solei, Canaca, HEXO, Redecan, Original Stash, Bake Sale, XMG, Mollo, and others.
Ticker
TLRY
Sector
Healthcare
Trading on
NASDAQ
Industry
Biotechnology & Drugs
Headquarters
New york, United States
Employees
1,600
Website
www.tilray.com
Tilray Metrics
BasicAdvanced
$1.5B
Market cap
-
P/E ratio
-$0.50
EPS
2.26
Beta
-
Dividend rate
Price and volume
Market cap
$1.5B
Beta
2.26
52-week high
$3.40
52-week low
$1.50
Average daily volume
742
Financial strength
Current ratio
1.918
Quick ratio
1.176
Long term debt to equity
10.358
Total debt to equity
13.695
Interest coverage (TTM)
0.23%
Management effectiveness
Return on assets (TTM)
-7.61%
Return on equity (TTM)
-10.41%
Return on investment (TTM)
-8.38%
Valuation
Price to revenue (TTM)
2
Price to book
0.415
Price to tangible book (TTM)
3.547
Growth
Revenue change (TTM)
24.65%
Earnings per share change (TTM)
83.80%
What the Analysts think about Tilray
Analyst Ratings
Majority rating from 16 analysts.
Tilray Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$188M
-2.79%
Net income
-$93M
89.18%
Profit margin
-49.22%
94.62%
Tilray Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
-$0.15
-$0.10
-$0.07
-$0.12
-
Expected
-$0.05
-$0.06
-$0.06
-$0.05
-$0.03
Surprise
210.35%
81.82%
20.69%
140.00%
-
Tilray News
AllArticlesVideos
Tilray Medical Granted Approval to Introduce Third Medical Cannabis Product in Portugal
GlobeNewsWire·3 days ago
Tilray secures new cannabis cultivation license in Germany: Is it time to buy TLRY?
Invezz·5 days ago
Tilray Receives First New Cannabis Cultivation License in Germany Under New Regulations
GlobeNewsWire·5 days ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Tilray stock?
Tilray (TLRY) has a market cap of $1.5B as of July 27, 2024.
What is the P/E ratio for Tilray stock?
The price to earnings (P/E) ratio for Tilray (TLRY) stock is 0 as of July 27, 2024.
Does Tilray stock pay dividends?
No, Tilray (TLRY) stock does not pay dividends to its shareholders as of July 27, 2024.
When is the next Tilray dividend payment date?
Tilray (TLRY) stock does not pay dividends to its shareholders.
What is the beta indicator for Tilray?
Tilray (TLRY) has a beta rating of 2.26. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.
Buy or sell Tilray stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.